4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/PFI-1/SYN-3041-M050/50 mg
商品详细Adipogen/PFI-1/SYN-3041-M050/50 mg
Adipogen/PFI-1/SYN-3041-M050/50 mg
Adipogen/PFI-1/SYN-3041-M050/50 mg
商品编号: SYN-3041-M050
品牌: Adipogen Inc
市场价: ¥8420.00
美元价: 5052.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
More Information
Product Details
Synonyms 2-Methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide; PF-06405761
Product Type Chemical
Properties
Formula C16H17N3O4S
MW 347.4
CAS 1403764-72-6
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO.
Declaration Manufactured by SynKinase.
Other Product Data Target: BET, BrD4 | Kinase Group: N/A | Substrate: N/A

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key TXZPMHLMPKIUGK-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
PFI-1 efficiently and selectively blocks the interaction of BET BRDs with acetylated histone tails. PFI-1 displaces histone 4 peptide acetylated at lysines K5, K8, K12 and K16 (H4K5acK8acK12acK16ac) with a potency (IC50) of 220nM for BRD4 and 98nM for BRD2. Exposure of sensitive cell lines with PFI-1 results in G1 cell cycle arrest, down-regulation of MYC expression as well as induction of apoptosis and induces differentiation of primary leukaemic blasts.
Product References
  1. Selective inhibition of BET bromodomains: P. Filippakopoulos, et al.; Nature 468, 1067 (2010)
  2. PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains: S. Picaud, et al.; Cancer Res. 73, 3336 (2013)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。